Prices of Janssen’s Prezista, Dacogen to be made public in August

Published: 2008-07-17 06:50:00

Updated: 2008-07-17 06:50:00

The Ministry of Health, Welfare and Family Affairs says it will announce terms for health insurance allowance for Prezista tablet and Dacogen injection next month due to Janssen Korea’ request to delay the price notice.

Prezista (darunavir or TMC-114), a protease inhibitor indicated for the tr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK